Anna Jonebring
Impact in
-
- Pluripotent Stem Cells Research
- Renal and related cancers
- Congenital heart defects research
-
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Pluripotent Stem Cells Research 6
- Viral Infectious Diseases and Gene Expression in Insects 2
- Congenital heart defects research 2
- Renal and related cancers 1
- CRISPR and Genetic Engineering 1
-
- Hemophilia Treatment and Research 1
- Co-authors
- Gabriella Brolén (2 shared papers)Alleyn T. Plowright (3 shared papers)Lauren Drowley (3 shared papers)Qing-Dong Wang (3 shared papers)Ian A. Cotgreave (1 shared paper)Xueqing Li (1 shared paper)Björn Glinghammar (1 shared paper)Ryan Hicks (3 shared papers)
- Journals
- The Protein Journal (2 papers)Scientific Reports (2 papers)Stem Cells Translational Medicine (1 paper)Stem Cell Research (1 paper)Biomaterials Science (1 paper)
- Partner nations
- SwedenUnited KingdomCanada
In The Last Decade
Anna Jonebring
10 papers receiving 341 citations
Peers
Comparison fields: 5 of 46
- Molecular Biology 184
- Pharmacology 27
- Biomaterials 19
- Nephrology 14
- Surgery 51
Countries citing papers authored by Anna Jonebring
This map shows the geographic impact of Anna Jonebring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Jonebring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Jonebring more than expected).
Fields of papers citing papers by Anna Jonebring
This network shows the impact of papers produced by Anna Jonebring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Jonebring. The network helps show where Anna Jonebring may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Jonebring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 67 | |
| 2 | 2018 | 61 | |
| 3 | 2017 | 56 | |
| 4 | 2020 | 47 | |
| 5 | 2015 | 34 | |
| 6 | 2022 | 22 | |
| 7 | 2021 | 19 | |
| 8 | 2014 | 17 | |
| 9 | 2016 | 16 | |
| 10 | 2012 | 12 |
About Anna Jonebring
Anna Jonebring is a scholar working on Molecular Biology, Hematology, Small Animals, Pharmacology and Genetics, having authored 10 papers that have together received 351 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Congenital heart defects research (2 papers), Hemophilia Treatment and Research (1 paper), Tissue Engineering and Regenerative Medicine (1 paper), Renal and related cancers (1 paper), Venomous Animal Envenomation and Studies (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Molecular Biology (184 citations), Pharmacology (27 citations), Biomaterials (19 citations), Nephrology (14 citations) and Surgery (51 citations). Anna Jonebring has collaborated with scholars based in Sweden, United Kingdom and Canada. Frequent co-authors include Gabriella Brolén, Alleyn T. Plowright, Lauren Drowley, Qing-Dong Wang, Ian A. Cotgreave, Xueqing Li, Björn Glinghammar, Ryan Hicks, Anna-Karin M. Sjogren and Tommy B. Andersson. Their work appears in journals such as The Protein Journal, Scientific Reports, Stem Cells Translational Medicine, Stem Cell Research and Biomaterials Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.